Cite Filings / LENZ / 0001628280-25-017187

Feed Companies Filings Check

Sign in

424B3

Prospectus

LENZ Therapeutics, Inc. Filed 2025-04-09 Acc 0001628280-25-017187

Documents 1

424B3 Prospectus , a424b3march2024financing.htm

Around this filing

2025-04-10 CORRESP Correspondence Between Filers and SEC Staff
2025-04-09 4 Chief Commercial Officer acquired 1,400 shares (option exercise)
2025-04-09 424B3 Prospectus
2025-04-09 424B3 Prospectus
2025-04-08 EFFECT Notice of Effectiveness
2025-04-08 EFFECT Notice of Effectiveness
2024-11-06 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a424b3march2024financing.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…